Abstract

Measures of lung function are heritable, and thus, we sought to utilise genetics to propose drug repurposing candidates that could improve respiratory outcomes. Lung function measures were found to be genetically correlated with seven druggable biochemical traits, with further evidence of a causal relationship between increased fasting glucose and diminished lung function. Moreover, we developed polygenic scores for lung function specifically within pathways with known drug targets and investigated their relationship with pulmonary phenotypes and gene expression in independent cohorts to prioritise individuals who may benefit from particular drug repurposing opportunities. A transcriptome-wide association study (TWAS) of lung function was then performed which identified several drug-gene interactions with predicted lung function increasing modes of action. Drugs that regulate blood glucose were uncovered through both the polygenic scoring and TWAS methodologies. In summary, we provided genetic justification for a number of novel drug repurposing opportunities that could improve lung function.

Data availability

All data are publicly available from the references described in the manuscript. Code related to this study can be found at the following link: https://github.com/Williamreay/Lung_function_drug_repurposing_manuscript

The following previously published data sets were used

Article and author information

Author details

  1. William R Reay

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    Competing interests
    William R Reay, has filed a patent related to the use of the pharmagenic enrichment score methodology in complex disorders. This competing interest only applies to that section of the manuscript. WIPO Patent Application WO/2020/237314..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7689-2453
  2. Sahar I El Shair

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  3. Michael P Geaghan

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  4. Carlos Riveros

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  5. Elizabeth G Holliday

    School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  6. Mark A McEvoy

    School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  7. Stephen Hancock

    School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  8. Roseanne Peel

    School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  9. Rodney J Scott

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  10. John R Attia

    School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
    Competing interests
    No competing interests declared.
  11. Murray J Cairns

    School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
    For correspondence
    murray.cairns@newcastle.edu.au
    Competing interests
    Murray J Cairns, has filed a patent related to the use of the pharmagenic enrichment score methodology in complex disorders. This competing interest only applies to that section of the manuscript. WIPO Patent Application WO/2020/237314..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2490-2538

Funding

National Health and Medical Research Council (1147644)

  • Murray J Cairns

National Health and Medical Research Council (1121474)

  • Murray J Cairns

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The use of the Hunter Community Cohort data was approved by the University of Newcastle Human Ethics Research Committee (HREC, reference: H-820-0504a). All other information related to ethical approval for the individual GWAS studies we utilised in this study are detailed in their respective publications as referenced throughout the text

Copyright

© 2021, Reay et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. William R Reay
  2. Sahar I El Shair
  3. Michael P Geaghan
  4. Carlos Riveros
  5. Elizabeth G Holliday
  6. Mark A McEvoy
  7. Stephen Hancock
  8. Roseanne Peel
  9. Rodney J Scott
  10. John R Attia
  11. Murray J Cairns
(2021)
Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function
eLife 10:e63115.
https://doi.org/10.7554/eLife.63115

Share this article

https://doi.org/10.7554/eLife.63115

Further reading

    1. Genetics and Genomics
    Daigo Miyazaki, Mitsuto Sato ... Akinori Nakamura
    Research Article

    Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of Duchenne muscular dystrophy (DMD). BMD severity varies from asymptomatic to severe, associated with the genotype of DMD. However, the underlying mechanisms remain unclear. We established BMD mice carrying three representative exon deletions: ex45–48 del., ex45–47 del., and ex45–49 del. (d45–48, d45–47, and d45–49), with high frequencies and different severities in the human BMD hotspot. All three BMD mice showed muscle weakness, muscle degeneration, and fibrosis, but these changes appeared at different times for each exon deletion, consistent with the severities obtained by the natural history study of BMD. BMD mice showed site-specific muscle changes, unlike mdx mice, which showed diffuse muscle changes, and we demonstrated selective type IIa fiber reduction in BMD mice. Furthermore, BMD mice showed sarcolemmal neuronal nitric oxide synthase (nNOS) reduction and morphological capillary changes around type IIa fibers. These results suggest that capillary changes caused by nNOS reduction may be associated with the mechanism of skeletal muscle degeneration and type IIa fiber reduction in BMD mice. BMD mice may be useful in elucidating the pathomechanisms and developing vascular targeted therapies for human BMD.

    1. Evolutionary Biology
    2. Genetics and Genomics
    James Boocock, Noah Alexander ... Leonid Kruglyak
    Research Article

    Expression quantitative trait loci (eQTLs) provide a key bridge between noncoding DNA sequence variants and organismal traits. The effects of eQTLs can differ among tissues, cell types, and cellular states, but these differences are obscured by gene expression measurements in bulk populations. We developed a one-pot approach to map eQTLs in Saccharomyces cerevisiae by single-cell RNA sequencing (scRNA-seq) and applied it to over 100,000 single cells from three crosses. We used scRNA-seq data to genotype each cell, measure gene expression, and classify the cells by cell-cycle stage. We mapped thousands of local and distant eQTLs and identified interactions between eQTL effects and cell-cycle stages. We took advantage of single-cell expression information to identify hundreds of genes with allele-specific effects on expression noise. We used cell-cycle stage classification to map 20 loci that influence cell-cycle progression. One of these loci influenced the expression of genes involved in the mating response. We showed that the effects of this locus arise from a common variant (W82R) in the gene GPA1, which encodes a signaling protein that negatively regulates the mating pathway. The 82R allele increases mating efficiency at the cost of slower cell-cycle progression and is associated with a higher rate of outcrossing in nature. Our results provide a more granular picture of the effects of genetic variants on gene expression and downstream traits.